Strategic Governance Milestone: VAi Leadership Representation on the AVMI Board
Prof. Dr. Alexzander Asea, Chief Executive Officer of the Vaccine Access Initiative (VAI) a subsidiary of Microhaem Scientifics (MHS) was elected to the Board of the African Vaccine Manufacturing Initiative (AVMI), the continent’s principal platform shaping policy, advocacy, and investment alignment for sustainable vaccine manufacturing in Africa. AVMI operates at the intersection of government policy, […]
Strategic Governance Milestone: VAi Leadership Representation on the AVMI Board Read More »